Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/56481
Title: | [COVID-19 vaccination: the reality after clinical trials]. | |
Other Titles: | Vacunación anti-COVID-19: La realidad tras los ensayos clínicos. | |
Authors: | ||
Keywords: | ||
Mesh: | ||
Issue Date: | 28-Apr-2021 | |
Citation: | Rev Esp Quimioter.2021;(34)5:408-418 | |
Abstract: | After the start of vaccination against SARS-CoV-2, enough clinical experience is already accumulating, in the real world and outside clinical trials, to resolve some of the questions that are still pending about this problem. The Scientific Committee on COVID-19 of the Madrid College of Physicians has discussed and reviewed some of these issues with a multidisciplinary approach. The following document is an attempt to answer some of these questions with the information available so far. This document is structured in questions on different aspects of the indications, efficacy and tolerance of anti-COVID-19 vaccination. | |
PMID: | 33906339 | |
URI: | https://hdl.handle.net/20.500.12530/56481 | |
Rights: | openAccess | |
Appears in Collections: | Centros de Atención Primaria > Artículos | |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PMC8638833.pdf | 213.33 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.